← Back to Search

Active Brains Programs for Cognitive Impairment and Chronic Pain in Aging Adults

N/A
Recruiting
Led By Ana-Maria Vranceanu, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female outpatients, age 60 years or older
Have nonmalignant chronic pain for more than 3 months
Must not have
Diagnosed with dementia or neurodegenerative disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 weeks, 8 weeks, 6 months

Summary

This trial compares two online programs designed to help older adults with early cognitive decline and chronic pain. The programs involve group sessions that teach coping skills and strategies to manage symptoms. The goal is to improve physical, cognitive, and emotional well-being.

Who is the study for?
This trial is for adults aged 60 or older with mild cognitive issues and chronic pain, who can use a smartphone app and fitness watch. They should be able to walk briskly for six minutes, not have dementia or worsening medical conditions, and either be off certain medications for two weeks or on a stable dose.
What is being tested?
The study compares two virtual programs called Active Brains 1 & 2 designed to manage symptoms in aging individuals with early cognitive decline and chronic pain. It will evaluate improvements in physical, cognitive, and emotional functions over six months.
What are the potential side effects?
Since the interventions are non-pharmacological programs focusing on symptom management through virtual means like Zoom sessions, significant side effects are not anticipated as commonly seen with medication trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I have had chronic pain not caused by cancer for over 3 months.
Select...
I can walk quickly for 6 minutes without stopping.
Select...
I am mostly independent in my daily activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with dementia or a similar brain condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 weeks, 8 weeks, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks, 8 weeks, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in PROMIS Physical Function
Change in Step Count via the ActiGraph wGT3X-BTLE Accelerometer
Change in six-minute walk test (6MWT)
Secondary study objectives
Everyday Cognition Scale (eCog-12)
Numerical Rating Scale
PROMIS Anxiety
+2 more
Other study objectives
Change in PROMIS Pain Interference - Short Form 6b V1.0
Global Cognitive and Social Engagement
Gratitude Questionnaire
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Brains 1Experimental Treatment1 Intervention
Active Brains 1 uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions and weekly practice assignments (homework). The Active Brains sessions teach skills and strategies to manage early cognitive concerns and chronic pain. The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.
Group II: Active Brains 2Placebo Group1 Intervention
This active comparison condition controls for the effect of time spent, group member support/feedback and interventionist support/feedback. Active Brains 2 addresses population-specific challenges of chronic pain and early cognitive decline symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight" and "Medical appointments". The Active Brains 2 program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The Active Brains 2 is conducted in the same format as Active Brains 1, but participants are not taught the mind-body, walking or cognitive-behavioral skills. Active Brains 2 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Brains 1
2019
N/A
~30

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Virtual symptom management programs for chronic pain, such as those studied in Active Brains 1 and Active Brains 2, often include cognitive-behavioral therapy (CBT), physical exercise, and mindfulness-based stress reduction (MBSR). CBT helps reframe negative thoughts and develop coping strategies, reducing pain perception and improving emotional well-being. Physical exercise enhances muscle strength and flexibility, reducing pain and improving physical function. Mindfulness practices manage stress and emotional responses to pain, lowering overall pain perception. These mechanisms are vital as they provide a comprehensive approach to managing chronic pain, addressing physical, psychological, and emotional aspects.
Innovative Technology Using Virtual Reality in the Treatment of Pain: Does It Reduce Pain via Distraction, or Is There More to It?A Systematic Review of Technology-assisted Self-Management Interventions for Chronic Pain: Looking Across Treatment Modalities.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,015 Previous Clinical Trials
13,309,100 Total Patients Enrolled
30 Trials studying Chronic Pain
4,753 Patients Enrolled for Chronic Pain
Ana-Maria Vranceanu, PhDPrincipal InvestigatorMassachusetts General Hospital
20 Previous Clinical Trials
1,819 Total Patients Enrolled
5 Trials studying Chronic Pain
424 Patients Enrolled for Chronic Pain

Media Library

Active Brains 1 Clinical Trial Eligibility Overview. Trial Name: NCT05373745 — N/A
Chronic Pain Research Study Groups: Active Brains 2, Active Brains 1
Chronic Pain Clinical Trial 2023: Active Brains 1 Highlights & Side Effects. Trial Name: NCT05373745 — N/A
Active Brains 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT05373745 — N/A
~80 spots leftby Dec 2025